Skip to Content

TEVA 2049 TEVA 2049 (Tolterodine tartrate extended-release 4 mg)

Pill imprint TEVA 2049 TEVA 2049 has been identified as Tolterodine tartrate extended-release 4 mg.

Tolterodine is used in the treatment of overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Tolterodine 4 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tolterodine tartrate extended-release 4 mg TEVA 2049 TEVA 2049
Tolterodine tartrate extended-release 4 mg TEVA 2049 TEVA 2049
Discount Card Promo
Tolterodine tartrate extended-release
TEVA 2049 TEVA 2049
4 mg
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.